Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangmeng Fu

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|May 16, 2015
[Analysis of prognostic parameters in patients with breast cancer of size smaller than or equal to 2 cm]Cheng Xue, Fangmeng Fu, Chuan Wang
The Surgical Clinics of North America|July 15, 2018
Ductal Carcinoma In SituFangMeng Fu, Richard C Gilmore, Lisa K Jacobs
International Journal of Molecular Medicine|December 21, 2013
RhoBTB2 gene in breast cancer is silenced by promoter methylationWeiwei Tang, Chuan Wang, Fangmeng Fu, et al.
Translational Cancer Research|February 4, 2022
Effect of node status on breast cancer survival by subtype: a single-center retrospective cohort studyWeibin Lian, Fangmeng Fu, Debo Chen, et al.
Plos One|June 28, 2013
Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-AnalysisChuan Wang, Minyan Chen, Fangmeng Fu, et al.
Plos One|December 23, 2014
Associations of two common genetic variants with breast cancer risk in a chinese population: a stratified interaction analysisYuxiang Lin, Fangmeng Fu, Minyan Chen, et al.
The Tohoku Journal of Experimental Medicine|March 1, 2012
Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han womenFangmeng Fu, Chuan Wang, Meng Huang, et al.
Cancer Management and Research|October 30, 2020
A Model to Predict the Risk of Lymph Node Metastasis in Breast Cancer Based on Clinicopathological CharacteristicsWenxin Chen, Chuan Wang, Fangmeng Fu, et al.
Frontiers in Oncology|May 20, 2021
LncRNA PCIR Is an Oncogenic Driver <i>via</i> Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast CancerWenhui Guo, Jingyi Li, Haobo Huang, et al.
The Journal of Surgical Research|February 22, 2025
Expression and Subtype Discordance Between Core Needle Biopsy and Surgical Specimen in Breast CancerMin Xu, Yiwei Yan, Yueqin Chen, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|May 16, 2015
[Analysis of prognostic parameters in patients with breast cancer of size smaller than or equal to 2 cm]Cheng Xue, Fangmeng Fu, Chuan Wang
The Surgical Clinics of North America|July 15, 2018
Ductal Carcinoma In SituFangMeng Fu, Richard C Gilmore, Lisa K Jacobs
International Journal of Molecular Medicine|December 21, 2013
RhoBTB2 gene in breast cancer is silenced by promoter methylationWeiwei Tang, Chuan Wang, Fangmeng Fu, et al.
Translational Cancer Research|February 4, 2022
Effect of node status on breast cancer survival by subtype: a single-center retrospective cohort studyWeibin Lian, Fangmeng Fu, Debo Chen, et al.
Plos One|June 28, 2013
Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-AnalysisChuan Wang, Minyan Chen, Fangmeng Fu, et al.
Plos One|December 23, 2014
Associations of two common genetic variants with breast cancer risk in a chinese population: a stratified interaction analysisYuxiang Lin, Fangmeng Fu, Minyan Chen, et al.
The Tohoku Journal of Experimental Medicine|March 1, 2012
Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han womenFangmeng Fu, Chuan Wang, Meng Huang, et al.
Cancer Management and Research|October 30, 2020
A Model to Predict the Risk of Lymph Node Metastasis in Breast Cancer Based on Clinicopathological CharacteristicsWenxin Chen, Chuan Wang, Fangmeng Fu, et al.
Frontiers in Oncology|May 20, 2021
LncRNA PCIR Is an Oncogenic Driver <i>via</i> Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast CancerWenhui Guo, Jingyi Li, Haobo Huang, et al.
The Journal of Surgical Research|February 22, 2025
Expression and Subtype Discordance Between Core Needle Biopsy and Surgical Specimen in Breast CancerMin Xu, Yiwei Yan, Yueqin Chen, et al.
Pageof 9